Transplant Oncology: A Frontier in Multidisciplinary Cancer Care

Author: Abdelrahim MD PhD Pharm.B, Maen A.

Brand: Academic Press

Edition: 1

ISBN: 9780443219016

Release Date: 22-11-2024

Package Dimensions: 10.9 x 8.4 x 1.0 inches

Languages: English

Binding: paperback

Number Of Pages: 360

Details: **Selected for 2025 Doody’s Core Titles® in Transplantation Surgery**

Transplant Oncology: A Frontier in Multidisciplinary Cancer Care summarizes new and evolving scientific findings and discoveries in the field of cancer and transplants and gives guidance on future directions and related research. With a strong focus on transplant oncology, the book examines new and evolving topics, including the utilization of immunotherapy in special patient populations as well as the clinical updates on new concepts in the field such as using circulating tumor DNA (ctDNA) as a tool for minimal disease detection, surveillance, and treatment response evaluation as well as rejection assessment and detection in transplant patient for oncological indications.

Sections cover applications of transplant medicine and surgery in oncology to improve patient survival outcome and quality of life. The book gives insight into anticancer strategies, such as initiating studies in genomics and cancer immunogenomics based on new insights in liver cancer.
In addition, it describes how the adoption of surgical transplantation techniques in oncology has improved conventional resection and bridged the gap between tumor and transplant immunology. This is a must have reference for all those that want to be familiar and up-to-date with the dynamic changes in the field including practicing physicians, scientists, and trainees. Illustrates the concept and history of transplant oncology as an evolving field for the management of hepatocellular carcinoma Discusses the utility and safety of immunotherapy in the transplant setting Summarizes the utilization of immune checkpoint inhibitor therapies in pre-and post-liver transplants for HCC patients and discusses the assessment of immune checkpoint inhibitor regulators that might determine liver transplant outcomes Highlights new and evolving topics including the utilization of immunotherapy in special patient populations as well as the clinical updates on new concepts in the field, including treatment and rejection assessment